ロード中...
Age-associated difference in circulating ACE2, the gateway for SARS-COV-2, in humans: results from the InCHIANTI study
Levels of angiotensin-converting enzyme 2 (ACE2), the gateway for COVID-19 virus into the cells, have been implicated in worse COVID-19 outcomes associated with aging and cardiovascular disease (CVD). Data on age-associated differences in circulating ACE2 levels in humans and the role of CVD and med...
保存先:
| 出版年: | GeroScience |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7813532/ https://ncbi.nlm.nih.gov/pubmed/33462706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-020-00314-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|